CIK 0001267565
- Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- Phone
- +1 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-15 | Heffernan Michael Thomas Chairman, President and CEO | Sale | −50,000 | $15.53 | $777K | 558,987 |
| 2017-10-25 | Fleming Alison B Chief Technology Officer | Option exercise | +1,811 | $3.38 | $6K | 26,563 |
| 2017-10-25 | Fleming Alison B Chief Technology Officer | Option exercise · Stock option (right to purchase) | −1,811 | 0 | ||
| 2017-08-09 | Melincoff Gwen A Director | Grant or award · Stock Option (Right to Purchase) | +25,067 | 25,067 | ||
| 2017-08-04 | Heffernan Michael Thomas Chairman, President and CEO | Shares withheld for taxes | −736 | $12.39 | $9K | 608,987 |
| 2017-08-04 | Brannelly Paul Executive Vice President & CFO | Shares withheld for taxes | −200 | $12.39 | $2K | 110,803 |
| 2017-08-04 | Fleming Alison B Chief Technology Officer | Shares withheld for taxes | −200 | $12.39 | $2K | 24,752 |
| 2017-07-28 | Heffernan Michael Thomas Chairman, President and CEO | Grant or award | +640 | $10.60 | $7K | 609,723 |
| 2017-07-28 | Brannelly Paul Executive Vice President & CFO | Grant or award | +776 | $10.60 | $8K | 111,003 |
| 2017-07-28 | Fleming Alison B Chief Technology Officer | Grant or award | +639 | $10.60 | $7K | 24,952 |
| 2017-05-31 | Ciaffoni Joseph Chief Operating Officer | Grant or award | +84,268 | 84,268 | ||
| 2017-05-31 | Ciaffoni Joseph Chief Operating Officer | Grant or award · Stock Option (Right to Purchase) | +259,283 | 259,283 | ||
| 2017-05-24 | SANTINI GINO Director | Grant or award · Stock Option (Right to Purchase) | +19,853 | 19,853 | ||
| 2017-05-24 | BOHLIN GAREN G Director | Grant or award · Stock Option (Right to Purchase) | +19,853 | 19,853 | ||
| 2017-05-24 | Schroeder Theodore R Director | Grant or award · Stock Option (Right to Purchase) | +19,853 | 19,853 | ||
| 2017-05-24 | Fallon John A. Director | Grant or award · Stock Option (Right to Purchase) | +19,853 | 19,853 | ||
| 2017-05-24 | Hirsch David Director | Grant or award · Stock Option (Right to Purchase) | +19,853 | 19,853 | ||
| 2017-05-24 | Freund John Gordon Director | Grant or award · Stock Option (Right to Purchase) | +19,853 | 19,853 | ||
| 2017-05-12 | Brannelly Paul Executive Vice President & CFO | Purchase | +10,000 | $9.18 | $92K | 110,227 |
| 2017-03-17 | Heffernan Michael Thomas Chairman, President and CEO | Shares withheld for taxes | −1,472 | $14.95 | $22K | 609,083 |
Page 35 of 41 · 811 trades